Effect of hospital systems on surgical outcomes in cancer patients.

e16449 Background: Individual hospitals are rapidly consolidating into large healthcare systems. While evidence exists on volume-outcome relationships for individual hospitals for the Whipple procedure, evidence on healthcare systems is lacking. We aim to compare outcomes for patients undergoing Whipple procedures between flagship and non-flagship hospitals to examine how hospital systems impact surgical quality for highly specialized surgical care. Methods: Utilizing New York State’s (NYS) Statewide Planning and Research Cooperative System, we identified adult patients who underwent Whipple’s procedure between 2016 and 2019. Patients were categorized into two cohorts: those treated in a flagship (highest volume hospital in a system) or non-flagship hospital. Free-standing hospitals and systems with fewer than 5 Whipple procedures annually at their flagship hospital were excluded (n = x). Patients with a non-pancreatic cancer that metastasized to the pancreases and patients with concomitant surgeries performed same-day were excluded (n = x). 1:1 propensity score matching was performed to balance cohorts for analysis. Patient characteristics and outcomes (30-day and 90-day) were analyzed between cohorts in unmatched and matched (on sex, race and insurance) samples using bivariate and multivariate analysis with alpha set at 0.05. Results: Overall, 1633 patients were included: 1126 (68.6%) received care at flagship hospitals and 515 (31.4%) at non-flagship hospitals. Whipple procedures were performed in X% of NYS hospitals including Y systems (Median hospitals per system: X). Patients treated at flagship hospitals were more often White (65% vs. 41%, p < 0.01) and less often Medicaid recipients (17% vs 30%, p < 0.01) versus non-flagship hospitals. After propensity-score-matching, patients at flagship hospitals had lower 30-day transfusion requirements (18% vs. 27%, p < 0.01), and overall fewer postoperative complications at 30-days (47% ) and 90-days (49% vs. 56%, p = 0.03) compared to patients in non-flagship hospitals in the same system; there was no difference in 90-day readmission (18% vs. 17%, p = 0.49) or mortality (2% vs 1%, p = 0.23). Conclusions: When planning a Whipple procedure, patients should be referred to the highest volume Whipple procedure hospital within their healthcare system to optimize post-operative outcomes. To facilitate access to high quality surgical services, providers should screen patients for social determinants or health and help connect patients with appropriate services to minimize patients burden and financial toxicities.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.e16449
Citations
1
Primary Topic
Advances in Oncology and Radiotherapy
Type
article
Field-Weighted Citation Impact
1.36
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of hospital systems on surgical outcomes in cancer patients.

Csaba Gajdos, Joseph C. L’Huillier, Katia Noyes, John M. Woodward et al.
1 citations
Journal of Clinical Oncology
Advances in Oncology and Radiotherapy
1.36
article

Effect of hospital systems on surgical outcomes in cancer patients.

Csaba Gajdos, Joseph C. L’Huillier, Katia Noyes, John M. Woodward, Ajay A. Myneni, Nader D. Nader, Han Liu, Miranda Berkebile
article en
1 citations

Abstract

e16449 Background: Individual hospitals are rapidly consolidating into large healthcare systems. While evidence exists on volume-outcome relationships for individual hospitals for the Whipple procedure, evidence on healthcare systems is lacking. We aim to compare outcomes for patients undergoing Whipple procedures between flagship and non-flagship hospitals to examine how hospital systems impact surgical quality for highly specialized surgical care. Methods: Utilizing New York State’s (NYS) Statewide Planning and Research Cooperative System, we identified adult patients who underwent Whipple’s procedure between 2016 and 2019. Patients were categorized into two cohorts: those treated in a flagship (highest volume hospital in a system) or non-flagship hospital. Free-standing hospitals and systems with fewer than 5 Whipple procedures annually at their flagship hospital were excluded (n = x). Patients with a non-pancreatic cancer that metastasized to the pancreases and patients with concomitant surgeries performed same-day were excluded (n = x). 1:1 propensity score matching was performed to balance cohorts for analysis. Patient characteristics and outcomes (30-day and 90-day) were analyzed between cohorts in unmatched and matched (on sex, race and insurance) samples using bivariate and multivariate analysis with alpha set at 0.05. Results: Overall, 1633 patients were included: 1126 (68.6%) received care at flagship hospitals and 515 (31.4%) at non-flagship hospitals. Whipple procedures were performed in X% of NYS hospitals including Y systems (Median hospitals per system: X). Patients treated at flagship hospitals were more often White (65% vs. 41%, p < 0.01) and less often Medicaid recipients (17% vs 30%, p < 0.01) versus non-flagship hospitals. After propensity-score-matching, patients at flagship hospitals had lower 30-day transfusion requirements (18% vs. 27%, p < 0.01), and overall fewer postoperative complications at 30-days (47% ) and 90-days (49% vs. 56%, p = 0.03) compared to patients in non-flagship hospitals in the same system; there was no difference in 90-day readmission (18% vs. 17%, p = 0.49) or mortality (2% vs 1%, p = 0.23). Conclusions: When planning a Whipple procedure, patients should be referred to the highest volume Whipple procedure hospital within their healthcare system to optimize post-operative outcomes. To facilitate access to high quality surgical services, providers should screen patients for social determinants or health and help connect patients with appropriate services to minimize patients burden and financial toxicities.

Journal of Clinical OncologyVol. 43(16_suppl)
Jacobs (United States) (US), University at Buffalo, State University of New York (US)
Openalex Percentile: Top 20%
Advances in Oncology and Radiotherapy
1.36
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.